Shares of Annovis Bio, Inc. (ANVS) have gained 23.8% over the past four weeks to close the last trading session at $11.10, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $35.40 indicates a potential upside of 218.9%.The average comprises five short-term price targets ranging from a low of $13 to a high of $72, with a standard deviation of $22.13. While the lowest estimate indic ...